The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis
Table 3
Demographic and laboratory results of the subclinical hypothyroid and the control group.
Subclinical hypothyroid
Control
Age (mean ± SD)
36.80 ± 8.19
35.42 ± 7.64
0.31
TSH (mIU/mL)
7.25 [IQR: 5.94–8.61]
1.88 [IQR: 1.46–2.50]
<0.0001
FT3 (ng/dL)
2.99 ± 0.36
3.32 ± 0.43
<0.0001
FT4 (ng/dL)
1.08 [IQR: 1.02–1.18]
1.20 [IQR: 1.13–1.34]
<0.0001
Total-C (mg/dL)
204.5 ± 40.9
176.4 ± 13.6
<0.0001
TG (mg/dL)
115 [IQR: 82.7–133.2]
81.50 [IQR: 69.7–110.75]
0.001
HDL-C (mg/dL)
56.34 ± 12.06
54.68 ± 10.96
0.51
LDL-C (mg/dL)
134 [IQR: 110–143]
108.5 [IQR: 97.75–117]
<0.0001
Lp(a) (mg/dL)
17.55 [IQR: 12.8–53.5]
17.45 [IQR: 10.95–22.02]
0.07
Excess Lp(a) percent (%)
: 21 (42%)
: 6 (12%)
0.001
BMI (kg/m2)
26.36 ± 2.22
24.9 ± 2.52
0.03
HOMA
1.68 ± 0.58
1.59 ± 0.62
0.43
Normally distributed values are indicated as mean ± SD; nonnormaly distributed values are indicated as median and interquartile ranges. TSH: thyroid stimulating hormone, FT4: free thyroxin, Total-C: total cholesterol, TG: triglyceride, HDL: high density lipoprotein, LDL: low density lipoprotein, Lp(a): lipoprotein(a), and BMI: body mass index; HOMA for insulin resistance index. values are the differences of subclinical hypothyroid and the control group.
